Patent · US Active

Modified polynucleotides for the production of secreted proteins

US10577403B2 · kind B2 · utility

39Cited by
29References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 12, 2019
Grant dateMar 3, 2020
Priority date—
Expiry dateJun 12, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2840/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.